Cytomark

Cytomark

Cell Stabilisation Reagents for use in Flow Cytometry

MENUMENU
  • Home
  • About
    • History
    • Meet the Team
    • Quality and Regulatory Assurance
  • TransFix®
  • Sample Stabilisation
    • Blood Collection Tubes
    • Cerebrospinal Fluid
    • Circulating Tumour Cells
    • Sample Storage
  • Flow Cytometry Essentials
  • Custom Products
  • Resources
    • News Feed
    • Bibliography
    • FAQ
    • Product Information
    • Marketing Resources
    • Safety and Quality
  • Contact Us
    • Distributors
    • Subscribe to the Cytomark Newsletter
    • Privacy Policy
Cytomark

Cytomark

Cell Stabilisation Reagents for use in Flow Cytometry

MENUMENU
  • Home
  • About
    • History
    • Meet the Team
    • Quality and Regulatory Assurance
  • TransFix®
  • Sample Stabilisation
    • Blood Collection Tubes
    • Cerebrospinal Fluid
    • Circulating Tumour Cells
    • Sample Storage
  • Flow Cytometry Essentials
  • Custom Products
  • Resources
    • News Feed
    • Bibliography
    • FAQ
    • Product Information
    • Marketing Resources
    • Safety and Quality
  • Contact Us
    • Distributors
    • Subscribe to the Cytomark Newsletter
    • Privacy Policy

Tag: Circulating Tumour Cells

13th March 2020 Cytomark

Preservation of mRNA from Isolated Circulating Tumour Cells

It is well documented that TransFix treated blood is compatible with isolation of circulating tumour cells, but new work published by Baird et al. describes a novel method of isolating CTCs, and the first published method of extracting mRNA from …

Read More
13th January 2019 Cytomark

Improved Stabilisation, Isolation, and Characterisation of Circulating Tumour Cells

A combination of technologies from French company ScreenCell and British company Cytomark has allowed for improved analysis of single circulating tumour cells. Circulating Tumour Cells The number of circulating tumour cell populations present in patient blood is very low, therefore …

Read More

Categories

  • CSF
  • CTC
  • Featured
  • Latest News
  • Other
  • SST
  • TFB
  • TVT

Recent News

  • White Paper: Evaluation of TransFix/EDTA CSF Sample Storage Tubes compared to alternative preservation methods
  • Preservation of CD34+ Stem Cells and Precursors with TransFix
  • Stabilisation of T-Cell Activation Markers
  • Stabilisation of Circulating Endothelial Progenitor Cells
  • TransFix Stabilisation of Blood Collected on Heparin Anticoagulants

Cytomark
a division of Caltag Medsystems

Caltag Medsytems

Quick Links:

  • News Feed
  • Quality and Regulatory Assurance
  • TransFix®
  • Sample Stabilisation
  • Product Information
  • Distributors
  • FAQ

Cytomark Ltd.

Whiteleaf Business Centre
11 Little Balmer
Buckingham
MK18 1TF
United Kingdom

+44 (0) 1280 827460

support@cytomark.co.uk

Subscribe to our Newsletter

Contact Us

ISO13485:2016

© 2015-2025 Cytomark Ltd.
Your Privacy
HTML Sitemap   XML Sitemap
Webmaster: AnnWebCom
Cytomark Ltd. is registered in the UK, No. 11863469. Registered Office: Whiteleaf Business Centre, 11 Little Balmer, Buckingham, MK18 1TF, UK. VAT Reg. No. GB 317 0847 08
Scroll